Safety, PK and Efficacy of 15 Days of SCY-635 Treatment in Hepatitis C Patients

Status:
Completed

Trial end date:
2009-01-01

Target enrollment:

Participant gender:

This study will examine the effectiveness of 15 days of therapy with SCY-635 in reducing hepatitis C virus (HCV) RNA levels.

Phase 1

Scynexis, Inc.